T-cell immunoglobulin and ITIM domain in cancer immunotherapy: A focus on tumor-infiltrating regulatory T cells
- 30 April 2022
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 147, 62-70
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cellsBlood, 2013
- The TIGIT/CD226 Axis Regulates Human T Cell FunctionThe Journal of Immunology, 2012
- Extrathymically generated regulatory T cells control mucosal TH2 inflammationNature, 2012
- Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic PerspectivesClinical Cancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in MiceGastroenterology, 2010
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityProceedings of the National Academy of Sciences, 2009
- A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DCEuropean Journal of Immunology, 2009
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cellsNature Immunology, 2008
- Natural versus adaptive regulatory T cellsNature Reviews Immunology, 2003